Three series of novel compounds derived from 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4carboxylic acid bearing piperazine carboxamides, (5-(substituted phenyl)-1,3,4-oxadiazol-2-yl) and (5-(alkylthio)-1,3,4-oxadiazol-2-yl) substitutions at the 4-position were synthesized. Synthesized compounds were characterized by 1 H NMR, 13 C NMR and mass spectral analysis and evaluated for their antimicrobial activities. Interestingly, most of the compounds exhibit moderate to good activities against tested Gram-positive, Gram-negative bacterial strains as well as fungal strains. ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
1,2,3-Triazole is a well known important heterocycle both in synthetic as well as medicinal chemistry due to its simple synthesis via click chemistry approach and a wide range of biological activities. Simple copper catalyzed 1,3-dipolar cycloadditions of substituted azides and alkynes afford regioselective 1,4-disubstitued 1,2,3-triazoles with high yields. 1,2,3-Triazole with high dipole moment, considerable stability and capability for hydrogen bonding make it a favorable binder of biomolecular targets. 1,2,3-Triazole derivatives were reported to exhibit various biological activities such as antidiabetic [1] , antitubercular [2, 3] , anti-inflammatory [4] , antifungal [5] [6] [7] , antiviral [8, 9] and antibacterial [10, 11] . Several drugs like carboxyamidotriazole, cefatrizine, and tazobactam bear 1,2,3triazole in their structure. Moreover, Rufinamide, the amide of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid is an antiepileptic drug, which is used in the treatment of partial seizures and drop attacks associated with the Lennox-Gastaut syndrome [12] .
Piperazines are considered as a useful and effective scaffold in drug design as they exhibit a wide range of biological activities such as FAAH and MAGL inhibitors [13] , human histamine H 4 antagonist [14] , and cannabinoid ligands [15] . Recently, piperazine bearing 1,2,3-triaozles are reported as potential anticancer, antiproliferative agents [16, 17] . On the other hand, 1,3,4oxadiazole is also a significant heterocycle that exhibit activities such as antimicrobial [18] [19] [20] [21] [22] [23] , anti-inflammatory, analgesic [24, 25] , antitubercular [26] [27] [28] , anticonvulsant [29] , antidiabetic [30] and anticancer [31] . In view of these findings and in continuation of our earlier attempts for the design and synthesis of novel azole containing heterocycles as possible antimicrobial and anti-inflammatory agents [32, 33] , we report herein the synthesis and antimicrobial evaluation of a series of piperazine carboxamide and 1,3,4-oxadiazole derivatives of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid as possible antimicrobial agents.
Experimental

Materials and measurements
All chemicals used were of laboratory grade and used without further purification. Melting points of compounds were determined in open capillary tubes in a silicon oil bath using a Veego melting point apparatus and are uncorrected. Purity of compounds was monitored by TLC on silica F 254 coated aluminum plates (Merck) as adsorbent and U.V. light and iodine as visualizing agents. 1 
2.2.2.
General procedure for the synthesis of (1-(2,6difluorobenzyl)-1H-1,2,3-triazol-4-yl)(4-substituted piperazin-1-yl)methanone (4a-k)
To a cooled solution of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid (3) (1.0 mol) in DMF (10 mL) was added HOBt (1.1 mol) followed by corresponding piperazine (1.1 mol) TEA (2.1 mol) and EDCAEHCl (1.1 mol). The reaction mixture was left overnight with stirring. The mixture was then poured onto crushed ice; the product was filtered and washed with water. The crude products (4a-k) were purified by column chromatography using hexane:EtOAc (9:1) as eluent. (5) To a solution of acid 3 in dry MeOH, a catalytic amount of conc. H 2 SO 4 was added and the mixture was then refluxed for 7-8 h. After the reaction was complete, excess solvent was removed under vacuum and crushed ice was added to the resulting solid. The solid was filtered and washed with water to obtain the product in 89% yield. mp: 132-135°C. The mixture of methyl ester 5 and hydrazine hydrate in ethanol was refluxed for 6 h on a water bath. After the reaction was complete, the reaction mixture was cooled. The solid thus obtained was filtered and washed with water. Yield 85%, mp: 229-231°C. 1 
General procedure for the synthesis of
The mixture of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4carbohydrazide 6 and corresponding substituted benzoic acid in POCl 3 was refluxed for 8 h. The reaction mixture was then cooled and poured onto the crushed ice. The solid separated was filtered, washed with water. The crude products (7a-g) were purified by column chromatography using hexane: EtOAc (8:2) as eluent. To a solution of carbohydrazide 6 (1.0 mol) in ethanol, an aqueous solution of potassium hydroxide (3.0 mol) was added. To this solution carbon disulfide (1.5 mol) was added and the resulting solution was refluxed in a water bath for 6 h. The reaction mass was cooled, acidified with acetic acid. The solid obtained was filtered, washed with water and dried to afford the target compound in 81% yield. mp: 203-205°C. 1 To a solution of compound 8 (1.0 mol) suspended in DMF, alkyl halide (1.2 mol) and a catalytic amount of triethylamine was added. The reaction mixture was then warmed in a water bath at 50°C for 3-4 h. After the reaction was complete as monitored on TLC, the mixture was cooled and poured onto crushed ice. The solid thus obtained was filtered, washed with water. The crude products (9a-e) were purified by column chromatography using hexane-ethyl acetate (8:2) as eluant. 
Results and discussion
Chemistry
Methodologies adopted for the synthesis of the title compounds 4a-k, 7a-g and 9a-e are shown in Schemes 1 and 2, respectively. Starting from commercially available 2,6-difluorobenzyl bromide 1, the corresponding 1-(2,6-difluorobenzyl)-1H-1,2,3triazole-4-carboxylic acid 3 was obtained by reported procedure [34] . 1 
Antimicrobial activity
The newly synthesized compounds were evaluated for their antibacterial activity against seven different bacterial strains, Tables 1 and 2 respectively. The investigation of antibacterial and antifungal screening results revealed that most of the test compounds exhibited moderate to good activities as compared to the standard drugs. Compounds 4e and 4g were active against all the tested species. Compound 4c was active against all the species except T. viride. Compounds 4b, 4c, 4e, and 4i were significantly effective against A. brasiliensis. Compounds 4e, 4g, 4h, and 4i were significantly active against C. albicans. Compound 4k was effective against E. coli, K. pneumonia, S. aureus, K. terrigena and A. flavus. In fact, it was the most active compound against S. aureus. Compounds 4c, 4e, and 4j showed significant inhibition of bacteria P. aeruginosa. For E. coli, 4k exhibited good activity. The most active compound against the B. subtilis was 4b. Compound 4g and 4i were active against S. pyogenes. The enhanced activities can be attributed to the presence of biologically active piperazine ring bearing different aryl substitutions at the nitrogen. In case of the 4-(5-(substituted aryl)-1,3,4-oxadiazol-2-yl)1H-1,2,3-triazole derivatives, almost all the title compounds showed moderate to good activities. Compound 7b was found to be most active against all the tested pathogens except K. pneumonia. Compound 7d was significantly active against all the species except P. aeruginosa. Compound 7f was found to be most active and comparable with the standard drug against T. viride. Compound 7e was good against bacteria P. aeruginosa. Against E. coli, 7a, and 7c exhibited good activity. It was noteworthy that almost all the compounds having halo-substituted phenyl rings at the 5position of the 1,3,4-oxadiazole ring exhibit significant activity against the tested microorganisms. When the aryl substitutions at the 5-position of the 1,3,4-oxadiazole ring were replaced by thioalkyl substitutions, compound 9a, 9b and 9c bearing ethyl, iso-propyl and n-butyl substitutions respectively, retained the activities. Although compound 9d and 9e were least active against the tested fungi, they retained activities against the bacterial strains. The overall results indicate that most of the synthesized compounds showed moderate to good activity against different tested microorganisms.
Conclusions
The present work reports the synthesis and in vitro biological evaluation of a new series of 1,4-disubstituted 1H-1,2,3-triazole derivatives having carboxamide and 1,3,4-oxadiazolyl substitutions at the 4-position. The antimicrobial study revealed that 1,2,3-triazole clubbed with 5-substituted 1,3,4oxadiazoles and N-substituted piperazines showed good activities against pathogenic strains. The presence of a piperazine ring, halo-substituted phenyl rings in the structure, enhanced the activities of the synthesized compounds. Further modifications of these new molecules are warranted which could provide more interesting results and new lead molecules for further studies.
